Investing.com - Dr Reddys Labs reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Dr Reddys Labs announced earnings per share of ₹0.46 on revenue of ₹585M. Analysts polled by Investing.com anticipated EPS of ₹0.42 on revenue of ₹555.38M.
Dr Reddys Labs shares are up 34.25% from the beginning of the year and are trading at ₹54.48 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Dr Reddys Labs follows other major Healthcare sector earnings this month
Dr Reddys Labs's report follows an earnings beat by J&J on July 16, who reported EPS of ₹1.67 on revenue of ₹18.34B, compared to forecasts EPS of ₹1.49 on revenue of ₹17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of ₹1.45 on revenue of ₹15.27B, compared to forecast for EPS of ₹1.42 on revenue of ₹15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar